These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 5511956)
1. [Serum-lipid reducing principles--possibilities for treatment. 8. Diet and drug treatment]. Hood B Lakartidningen; 1970 Dec; 67():Suppl IV:89+. PubMed ID: 5511956 [No Abstract] [Full Text] [Related]
2. [Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate]. Gustafson A Lakartidningen; 1970 Dec; 67():Suppl IV:75+. PubMed ID: 5511954 [No Abstract] [Full Text] [Related]
3. Diet and drugs in the treatment of hyperlipidemias. Med Lett Drugs Ther; 1970 May; 12(10):42-4. PubMed ID: 5514225 [No Abstract] [Full Text] [Related]
4. Treatment of hyperlipidemia. Margolis S Md State Med J; 1970 Nov; 19(11):101-3. PubMed ID: 5523343 [No Abstract] [Full Text] [Related]
5. Diet and drug therapy for hyperlipoproteinemia. Maha GE Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828 [No Abstract] [Full Text] [Related]
6. [Diagnosis and treatment of hyperlipoidaemias]. Wolfram G Munch Med Wochenschr; 1970 Oct; 112(40):1792 passim. PubMed ID: 5536214 [No Abstract] [Full Text] [Related]
8. [Antilipidemic agents]. Irsigler K; Flegel U Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):334-40. PubMed ID: 5148890 [No Abstract] [Full Text] [Related]
9. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia]. Warembourg H; Jaillard J Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605 [No Abstract] [Full Text] [Related]
10. [Effects of diet changes and use of dextrothyroxine and chlorphenisate on serum lipids]. Arteaga A; Cisternas H; Torres MC; Alliende ME Rev Med Chil; 1969 May; 97(5):285-90. PubMed ID: 5386042 [No Abstract] [Full Text] [Related]
11. [Serum-lipid reducing principles--possibilities for treatment. 4. Diet therapy for atherosclerosis]. Hedstrand H Lakartidningen; 1970 Dec; 67():Suppl IV:53+. PubMed ID: 5511952 [No Abstract] [Full Text] [Related]
12. Surgical treatment of hyperlipidemia. I. Apologia. Buchwald H; Moore RB; Varco RL Circulation; 1974 May; 49(5 Suppl):I1-12. PubMed ID: 4596500 [No Abstract] [Full Text] [Related]
13. [Serum-lipid reducing principles--possibilities for treatment. 1. General views on the treatment of hyperlipidemias]. Carlson LA Lakartidningen; 1970 Dec; 67():Suppl IV:33+. PubMed ID: 5511950 [No Abstract] [Full Text] [Related]
14. Serum lipid disorders: what levels should you aim for? Rees ED Geriatrics; 1981 Feb; 36(2):77-86. PubMed ID: 7450512 [No Abstract] [Full Text] [Related]
15. [Treatment of essential hyperlipemia with clofibrate]. Reuter W; Seifert A Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292 [No Abstract] [Full Text] [Related]
16. Clofibrate and androsterone effect on serum lipids. Orgain ES; Bogdonoff MD; Cain C Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838 [No Abstract] [Full Text] [Related]
17. Dietary fat restrictions and atromid therapy in patients with type II familial hyperlipoproteinemia. Sanbar SS; Zweifler AJ; Conway J Mich Med; 1968 Nov; 67(21):1346-7. PubMed ID: 5699513 [No Abstract] [Full Text] [Related]
18. [Biological exploration and basis of dietetic and pharmacological treatment for atheogenic hyperlipemia]. de Gennes JL Ann Cardiol Angeiol (Paris); 1973; 22(1):33-40. PubMed ID: 4704427 [No Abstract] [Full Text] [Related]
19. [Incidence of hyperlipoproteinemias, their classification and influencing through diet during a course of spa treatment. II. Clinical part]. Sachlová M; Hofman J; Zwetschke O Vnitr Lek; 1974 Jan; 20(1):15-27. PubMed ID: 4847012 [No Abstract] [Full Text] [Related]